Kazuyuki Kitatani (K Kitatani)

Scopus Author ID Scopus Author ID Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Setsunan University

Kyoto Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Setsunan University Apr 01 2018

Japan

Associate Professor :: Faculty of Pharmaceutical Sciences

Tohoku University Apr 01 2012 - Mar 31 2018

Japan

Assistant Professor :: Tohoku Medical Megabank Organization

Education History

Kyoto Pharmaceutical University Apr 01 1997 - Mar 31 2002

Japan

PHD :: Pathological Biochemistry

Publications

Yuki Ohya, Yuri Ogiso, Masaya Matsuda, Harumi Sakae, Kentaro Nishida, Yasuhiro Miki, Todd E Fox, Mark Kester, Wataru Sakamoto, Takeshi Nabe, Kazuyuki Kitatani
Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells. Cells 13 (5) (2024)
Yuki Ohya, Yuri Ogiso, Masaya Matsuda, Harumi Sakae, Kentaro Nishida, Yasuhiro Miki, Todd E Fox, Mark Kester, Wataru Sakamoto, Takeshi Nabe, Kazuyuki Kitatani
Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells. Cells 13 (5) (2024)
Yuki Ohya, Yuri Ogiso, Masaya Matsuda, Harumi Sakae, Kentaro Nishida, Yasuhiro Miki, Todd E Fox, Mark Kester, Wataru Sakamoto, Takeshi Nabe, Kazuyuki Kitatani
Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells. Cells 13 (5) (2024)
Harumi Sakae, Yuri Ogiso, Masaya Matsuda, Hayato Shimora, Tye Deering, Todd E Fox, Mark Kester, Takeshi Nabe, Kazuyuki Kitatani
Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma. Cells 12 (4) (2023)
Harumi Sakae, Yuri Ogiso, Masaya Matsuda, Hayato Shimora, Tye Deering, Todd E Fox, Mark Kester, Takeshi Nabe, Kazuyuki Kitatani
Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma. Cells 12 (4) (2023)
Harumi Sakae, Yuri Ogiso, Masaya Matsuda, Hayato Shimora, Tye Deering, Todd E Fox, Mark Kester, Takeshi Nabe, Kazuyuki Kitatani
Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma. Cells 12 (4) (2023)
Masaya Matsuda, Seito Shimizu, Kazuyuki Kitatani, Takeshi Nabe
Extracellular Vesicles Derived from Allergen Immunotherapy-Treated Mice Suppressed IL-5 Production from Group 2 Innate Lymphoid Cells. Pathogens (Basel, Switzerland) 11 (11) (2022)
Xuewei Zhang, Wataru Sakamoto, Daniel Canals, Masumi Ishibashi, Masaya Matsuda, Kentaro Nishida, Masafumi Toyoshima, Shogo Shigeta, Makoto Taniguchi, Can E Senkal, Toshiro Okazaki, Nobuo Yaegashi, Yusuf A Hannun, Takeshi Nabe, Kazuyuki Kitatani
Ceramide synthase 2-C24:1 -ceramide axis limits the metastatic potential of ovarian cancer cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 35 (2) (2021)
Xuewei Zhang, Masaya Matsuda, Nobuo Yaegashi, Takeshi Nabe, Kazuyuki Kitatani
Regulation of Necroptosis by Phospholipids and Sphingolipids. Cells 9 (3) (2020)
Xuewei Zhang, Masumi Ishibashi, Kazuyuki Kitatani, Shogo Shigeta, Hideki Tokunaga, Masafumi Toyoshima, Muneaki Shimada, Nobuo Yaegashi
Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer. Cancers 12 (6) (2020)
Masumi Ishibashi, Masafumi Toyoshima, Xuewei Zhang, Junko Hasegawa-Minato, Shogo Shigeta, Toshinori Usui, Christopher J Kemp, Carla Grandori, Kazuyuki Kitatani, Nobuo Yaegashi
Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer. Scientific reports 8 (1) (2018)
M Wada, Daniel Canals, M Adada, N Coant, M F Salama, K L Helke, J S Arthur, K R Shroyer, Kazuyuki Kitatani, L M Obeid, Y A Hannun
P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment. Oncogene 36 (47) (2017)

Kazuyuki Kitatani.css-eqlu8i{font-size:small;padding-left:4px;} (K Kitatani)

Publication Activity (10 Years)

Top Topics

Top Venues

Kazuyuki Kitatani (K Kitatani)